FNKFX
Price
$17.01
Change
+$0.18 (+1.07%)
Updated
Sep 26 closing price
Net Assets
1.14B
VIMSX
Price
$79.84
Change
+$0.88 (+1.11%)
Updated
Sep 26 closing price
Net Assets
199.16B
Interact to see
Advertisement

FNKFX vs VIMSX

Header iconFNKFX vs VIMSX Comparison
Open Charts FNKFX vs VIMSXBanner chart's image
Fidelity Mid-Cap Stock K6
Price$17.01
Change+$0.18 (+1.07%)
VolumeN/A
Net Assets1.14B
Vanguard Mid Cap Index Investor
Price$79.84
Change+$0.88 (+1.11%)
VolumeN/A
Net Assets199.16B
FNKFX vs VIMSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FNKFX vs. VIMSX commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNKFX is a Buy and VIMSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 199B vs. FNKFX (1.15B). VIMSX pays higher dividends than FNKFX: VIMSX (1.35) vs FNKFX (0.80). FNKFX was incepted earlier than VIMSX: FNKFX (6 years) vs VIMSX (27 years). FNKFX (0.45) is less costly to investors than VIMSX (0.17). FNKFX is a more actively managed with annual turnover of: 69.00 vs. VIMSX (16.00). FNKFX has a lower initial minimum investment than VIMSX: FNKFX (0) vs VIMSX (3000). VIMSX annual gain was more profitable for investors over the last year : 11.57 vs. FNKFX (2.20). FNKFX return over 5 years is better than : 81.21 vs. VIMSX (70.75).
FNKFXVIMSXFNKFX / VIMSX
Total Expense Ratio0.450.17265%
Annual Report Gross Expense Ratio0.450.17265%
Fund Existence6 years27 years-
Gain YTD6.97910.84564%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.15B199B1%
Annual Yield % from dividends0.801.3559%
Returns for 1 year2.2011.5719%
Returns for 3 years44.5955.7480%
Returns for 5 years81.2170.75115%
Returns for 10 yearsN/A160.66-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BALY10.790.34
+3.25%
Bally's Corporation
HAE48.170.50
+1.05%
Haemonetics Corp
PMCB0.97N/A
-0.10%
PharmaCyte Biotech
SLNH2.75-0.19
-6.46%
Soluna Holdings
MP68.63-8.50
-11.02%
MP Materials Corp